Average Co-Inventor Count = 4.38
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (29 from 2,076 patents)
2. Johnson & Johnson Pharmaceuticals Research & Development, L.l.c. (1 from 1 patent)
30 patents:
1. 12286429 - 5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors
2. 11958856 - Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors
3. 11919881 - Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors
4. 11897880 - 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
5. 11845748 - Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors
6. 11814364 - Pyridine N-oxide derivatives useful as factor XIa inhibitors
7. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
8. 11014917 - 5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
9. 10815210 - Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators
10. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
11. 10696662 - 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
12. 10251864 - Indole derivatives useful as glucagon receptor antagonists
13. 10214493 - Indazole derivatives useful as glucagon receptor antagonists
14. 10000473 - Indazole derivatives useful as glucagon receptor antagonists
15. 9045389 - Biphenyl derivatives useful as glucagon receptor antagonists